Cargando…
Acute Myocarditis Following the Administration of the Second BNT162b2 COVID-19 Vaccine Dose
COVID-19 disease has infected millions of people worldwide during the pandemic; hence, the need for an effective and safe vaccine was urgently required. A two-dose of the BNT162b2 mRNA COVID-19 vaccine was reported to have 95% efficacy in preventing COVID-19. The short-term safety profile recorded m...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Cureus
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8599115/ https://www.ncbi.nlm.nih.gov/pubmed/34804729 http://dx.doi.org/10.7759/cureus.18880 |